NB-1002

N/A

Report date: 2024/01/08 10:52:15

Base Information

Drug NameNB-1002
Drug Alias NameGLP-2- XTEN™NB-1002NB1002
ClassificationBiologics > Protein drugs > Recombinant polypeptide
Mechanisms of ActionGlucagon-like peptide 2 receptor agonists
TargetsGlucagon-like peptide 2 receptor
Therapy Area/IndicationsShort Bowel SyndromeGastrointestinal Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesAmunix Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesNaia LtdAmunix Pharmaceuticals Inc
Inactive CompaniesN/A
Active IndicationsShort Bowel SyndromeGastrointestinal Diseases
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A